Blue Jet Healthcare Ltd
Wed 7/01/2026,12:29:58 | NSE : BLUEJET
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 526.50
Previous Close
₹ 526.20
Volume
116673
Mkt Cap ( Rs. Cr)
₹9184.99
High
₹ 533.25
Low
₹ 521.60
52 Week High
₹ 1027.80
52 Week Low
₹ 512.40
Book Value Per Share
₹ 72.39
Dividend Yield
0.00
Face Value
₹ 2.00
What’s Your Call?
Collective community sentiment on Blue Jet Healthcare Ltd
Your Vote -
Buy
77.78%
Hold
0.00%
Sell
22.22%
77.78%
9 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
44%
Sell Order Quantity
56%
Bid Price
Qty
527.05
34
527.00
214
527.00
1
527.00
5
527.00
4
Bid Total
30195
Bid Price
Qty
527.25
56
527.00
5
527.00
22
527.00
5
528.00
34
Bid Total
38928
Option Chain
Analyzes market sentiment, predicts Blue Jet Healthcare Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Blue Jet Healthcare - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Blue Jet Healthcare - Trading Window
-
Blue Jet Healthcare - Credit Rating- New
-
Blue Jet Healthcare - Announcement under Regulation 30 (LODR)-Credit Rating
-
Blue Jet Healthcare - Updates
-
Blue Jet Healthcare - Update On Implementation Of 1.0 Of SAP S/4HANA By Blue Jet Healthcare Limited
-
Blue Jet Healthcare - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
-
Blue Jet Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates
-
Blue Jet Healthcare - Copy of Newspaper Publication
-
Blue Jet Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
-
Blue Jet Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates
-
Blue Jet Healthcare - Investor Presentation
-
Blue Jet Healthcare - Outcome of Board Meeting
-
Blue Jet Healthcare - Announcement under Regulation 30 (LODR)-Investor Presentation
-
Blue Jet Healthcare Q2 net profit down 10.64% at Rs 52.14 cr
-
Blue Jet Healthcare - Unaudited Financial Result For The Quarter And Half Year Ended September 30, 2025
-
Blue Jet Healthcare - Board Meeting Outcome for Unaudited Standalone Financial Result For The Quarter And Half Year Ended Sep
-
Blue Jet Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates
-
Blue Jet Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Blue Jet Healthcare - Board Meeting Intimation for Approval Of The Unaudited Standalone Financial Results For The Quarter And
-
Blue Jet Healthcare has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025
-
Blue Jet Healthcare - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Blue Jet Healthcare - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Key fundamentals
Evaluate the intrinsic value of Blue Jet Healthcare Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 1134.611 | 845.223 | 681.486 | 521.542 | 375.62 |
| Liabilities | 1134.611 | 845.223 | 681.486 | 521.542 | 375.62 |
| Equity | 34.693 | 34.693 | 34.693 | 34.693 | 9.912 |
| Gross Profit | 377.73 | 229.23 | 219.088 | 249.264 | 206.677 |
| Net Profit | 305.203 | 163.751 | 160.027 | 181.591 | 141.617 |
| Cash From Operating Activities | 45.764 | 241.257 | 141.556 | 146.417 | 136.78 |
| NPM(%) | 29.63 | 23.01 | 22.19 | 26.56 | 28.38 |
| Revenue | 1029.985 | 711.598 | 720.982 | 683.469 | 498.932 |
| Expenses | 652.255 | 482.368 | 501.894 | 434.205 | 292.255 |
| ROE(%) | 24.3 | 13.04 | 12.74 | 14.46 | 11.27 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|---|---|---|---|
| 19 Sep 2025 | 1.2 | 60 | 0 | 770.15 |
| 18 Sep 2024 | 1 | 50 | 0 | 379.3 |
Peers
Other companies within the same industry or sector that are comparable to Blue Jet Healthcare Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 755.50 | 1.31 | 0.00 | 300.51 | 301.39 | 0.66 |
| Lotus Eye Hospital and Institute Ltd | 119.11 | -1.17 | 372.22 | 1095.03 | 3.55 | 0.00 |
| Vaishali Pharma Ltd | 8.69 | -3.77 | 0.00 | 6869.48 | 3.13 | 0.00 |
| Astec Lifesciences Ltd | 694.90 | 0.07 | 0.00 | 1032.64 | -604.77 | 0.00 |
Company Info
The Company was originally incorporated as `Jet Chemicals Private Limited,' under the provisions of theCompanies Act, 1956, at Mumbai, pursuant to a certificate of incorporation dated December 7, 1968, issued by the Registrar of Companies, Maharashtra at Mumbai. Pursuant to the Shareholders' resolution dated December 28, 2020, the name of the Company was changed to `Blue Jet Healthcare Private Limited', and a fresh certificate of incorporation dated December 30, 2020, was issued by the Registrar of Companies, Maharashtra at Mumbai. Subsequently, the Company was converted into a public limited company, and pursuant to a special resolution of the Shareholders dated May 5, 2022, and the name of the Company was changed to `Blue Jet Healthcare Limited'. A fresh certificate of incorporation was issued by Registrar of Companies, Maharashtra, at Mumbai on May 18, 2022.Major events and milestones :1968- Established as Jet Chemicals Private Limited in Shahad (Unit I) by the late Shri B L Arora1970- Began manufacturing saccharin and its salts, which are high-intensity sweeteners2000- Entered the x-ray contrast media sector, with a basic building block (5- NIPA)2002- Commenced the manufacturing of pharma intermediates and API2003- Established Blue Circle Organics Private Limited (at Unit-II, Ambernath facility).2017- Commenced semi-automated manufacturing block for the contrast media intermediate business.2019- Received US FDA Establishment Inspection Report of Blue Circle Organics Private Limited for Unit II- As part of the corporate restructure strategy, a merger between Blue Circle Organics Private Limited and Jet Chemicals Private Limited was undertaken to form Blue Jet Healthcare Private Limited2020- Acquisition of brownfield site in Mahad on a leasehold basis (i.e., Unit III)2021- Acquisition of greenfield site in Ambernath on a leasehold basis (i.e., Unit IV) 2024 -The Company has successfully completed the Commissioning of production block to manufacture Advance Contrast Media on December 9, 2024. -The Company has received the prestigious award for Long Standing Impact on Community under the aegis of Huron India Most Respected Family Business Awards 2024 .
The Company was originally incorporated as `Jet Chemicals Private Limited,' under the provisions of theCompanies Act, 1956, at Mumbai, pursuant to a certificate of incorporation dated December 7, 1968, issued by the Registrar of Companies, Maharashtra at Mumbai. Pursuant to the Shareholders' resolution dated December 28, 2020, the name of the Company was changed to `Blue Jet Healthcare Private Limited', and a fresh certificate of incorporation dated December 30, 2020, was issued by the Registrar of Companies, Maharashtra at Mumbai. Subsequently, the Company was converted into a public limited company, and pursuant to a special resolution of the Shareholders dated May 5, 2022, and the name of the Company was changed to `Blue Jet Healthcare Limited'. A fresh certificate of incorporation was issued by Registrar of Companies, Maharashtra, at Mumbai on May 18, 2022.Major events and milestones :1968- Established as Jet Chemicals Private Limited in Shahad (Unit I) by the late Shri B L Arora1970- Began manufacturing saccharin and its salts, which are high-intensity sweeteners2000- Entered the x-ray contrast media sector, with a basic building block (5- NIPA)2002- Commenced the manufacturing of pharma intermediates and API2003- Established Blue Circle Organics Private Limited (at Unit-II, Ambernath facility).2017- Commenced semi-automated manufacturing block for the contrast media intermediate business.2019- Received US FDA Establishment Inspection Report of Blue Circle Organics Private Limited for Unit II- As part of the corporate restructure strategy, a merger between Blue Circle Organics Private Limited and Jet Chemicals Private Limited was undertaken to form Blue Jet Healthcare Private Limited2020- Acquisition of brownfield site in Mahad on a leasehold basis (i.e., Unit III)2021- Acquisition of greenfield site in Ambernath on a leasehold basis (i.e., Unit IV) 2024 -The Company has successfully completed the Commissioning of production block to manufacture Advance Contrast Media on December 9, 2024. -The Company has received the prestigious award for Long Standing Impact on Community under the aegis of Huron India Most Respected Family Business Awards 2024 .
Read More
Parent Organisation
Blue Jet Healthcare Ltd
Founded
07/12/1968
Managing Director
Mr.Shiven Akshay Arora
NSE Symbol
BLUEJETEQ
FAQ
The current price of Blue Jet Healthcare Ltd is ₹ 529.50.
The 52-week high for Blue Jet Healthcare Ltd is ₹ 533.25 and the 52-week low is ₹ 521.60.
The market capitalization of Blue Jet Healthcare Ltd is currently ₹ 9184.99. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Blue Jet Healthcare Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Blue Jet Healthcare Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Blue Jet Healthcare Ltd shares.
The CEO of Blue Jet Healthcare Ltd is Mr.Shiven Akshay Arora, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
